Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and DerivativesBusiness Overview: NCL is a WHO-GMP certified and ISO 9001, ISO 140001 compliance manufacturer of printed and unprinted hard two-piece Gelatin and Cellulose (HPMC : non-animal alternative) capsules for pharmaceutical and dietary supplement industries in various sizes of 00,...
Natural Capsules Ltd. reported Q1FY27 revenue of ₹48.71 Cr, up 8% YoY, with EBITDA at ₹1.12 Cr, a 251% YoY jump. PAT was (₹5.74 Cr), up 3% YoY, and EPS stood at (₹5.55), also up 3% YoY. The capsules business delivered a strong quarter with sustained demand and improved realizations,...
Natural Capsules (NCL) delivered ₹45.80 Cr revenue in Q2FY26, up 1.33% QoQ and 11.11% YoY. Despite revenue growth, NCL posted a net loss of ₹6.99 Cr (EBITDA: -₹0.88 Cr), reflecting significant pressure. For H1FY26, revenue hit ₹91.01 Cr (+13.18% YoY), with a net loss of ₹12.57 Cr. Q2FY26 EPS was...
Here is the financial summary: **Financial Highlights:** NCL reported Q1FY26 consolidated revenue of ₹45.20 Cr (+15.36% YoY). Profitability declined sharply, with EBITDA at ₹0.32 Cr (-92.69% YoY) and a net loss of ₹5.58 Cr, largely due to expenses from the new API facility. Management anticipates improved profitability as API revenues...
1. Financial Highlights: Natural Capsules posted consolidated revenue of ₹44.97 Cr in Q4FY25, up 11.8% YoY and 2.6% QoQ. EBITDA margin held steady at 9.74%, with EBITDA of ₹4.38 Cr. PAT declined 46% YoY to ₹0.52 Cr but improved sharply QoQ. For FY25, revenues grew 8.9% YoY to ₹169.21 Cr,...
